World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
83
Citations
31581
World Ranking
1421
National Ranking
95

Falk Nimmerjahn publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Falk Nimmerjahn sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 274 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Falk Nimmerjahn D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Falk Nimmerjahn sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 83 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Falk Nimmerjahn is affiliated with the University of Erlangen-Nuremberg in Germany. Their research predominantly spans the fields of Medicine and Immunology and Microbiology, with a focus on Immunology as a primary subfield. Other significant areas of study include Radiology, Nuclear Medicine and Imaging, Molecular Biology, Oncology, and Hematology.

Their work covers a range of topics, notably in Monoclonal and Polyclonal Antibodies Research, T-cell and B-cell Immunology, and Glycosylation and Glycoproteins Research. Additional key topics include Immune Cell Function and Interaction, Immunotherapy and Immune Responses, Cell Adhesion Molecules Research, and Platelet Disorders and Treatments.

Frequent publication venues for their research include Frontiers in Immunology, bioRxiv (Cold Spring Harbor Laboratory), Blood, Immunity, and Cell Reports. The scientist has authored numerous papers, some of the recent ones being:

  • Tissue-specific macrophages: how they develop and choreograph tissue biology, 2023, Nature reviews. Immunology
  • Ethanol consumption inhibits TFH cell responses and the development of autoimmune arthritis, 2020, Nature Communications
  • Stunning of neutrophils accounts for the anti-inflammatory effects of clodronate liposomes, 2023, The Journal of Experimental Medicine
  • There Is (Scientific) Strength in Numbers: A Comprehensive Quantitation of Fc Gamma Receptor Numbers on Human and Murine Peripheral Blood Leukocytes, 2020, Frontiers in Immunology
  • Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment, 2023, Nature Communications

Collaborations have been a significant aspect of their research approach. Frequent co-authors include Anja Lux, Diana Dudziak, Carmen Reitinger, Matthias Peipp, and Anja Werner, reflecting established scientific partnerships.

Best Publications

  • Fcγ receptors as regulators of immune responses

    Falk Nimmerjahn;Jeffrey V. Ravetch

  • Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

    Yoshikatsu Kaneko;Falk Nimmerjahn;Jeffrey V. Ravetch

  • Fcγ Receptors: Old Friends and New Family Members

    Falk Nimmerjahn;Jeffrey V. Ravetch

  • Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding

    Falk Nimmerjahn;Jeffrey V. Ravetch

  • Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc

    Robert M. Anthony;Falk Nimmerjahn;Falk Nimmerjahn;David J. Ashline;Vernon N. Reinhold

  • FcγRIV : A novel FcR with distinct IgG subclass specificity

    Falk Nimmerjahn;Pierre Bruhns;Ken Horiuchi;Jeffrey V. Ravetch

  • Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

    Inessa Schwab;Falk Nimmerjahn

  • Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin

    Ulrike Harre;Dan Georgess;Holger Bang;Aline Bozec

  • Anti-Inflammatory Actions of Intravenous Immunoglobulin

    Falk Nimmerjahn;Jeffrey V Ravetch

  • Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate.

    Hanne Schoenen;Barbara Bodendorfer;Kelly Hitchens;Silvia Manzanero

  • Tissue-specific macrophages: how they develop and choreograph tissue biology

    Unknown

  • Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1

    Christian M. Karsten;Manoj K. Pandey;Julia Figge;Regina Kilchenstein

  • Fc-receptors as regulators of immunity.

    Falk Nimmerjahn;Jeffrey V Ravetch

  • Mechanisms of Autoantibody-Induced Pathology.

    Ralf J. Ludwig;Karen Vanhoorelbeke;Frank Leypoldt;Ziya Kaya

  • Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy.

    Falk Nimmerjahn;Slavoljub Milosevic;Uta Behrends;Elizabeth M. Jaffee

  • Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ–Syk–Card9–dependent innate immune activation

    Kerstin Werninghaus;Anna Babiak;Olaf Groß;Christoph Hölscher

  • The antiinflammatory activity of IgG: the intravenous IgG paradox.

    Falk Nimmerjahn;Jeffrey V. Ravetch

  • Regulation of autoantibody activity by the IL-23-T H 17 axis determines the onset of autoimmune disease.

    René Pfeifle;Tobias Rothe;Natacha Ipseiz;Hans U Scherer

  • Antibody-mediated modulation of immune responses.

    Falk Nimmerjahn;Jeffrey V. Ravetch

  • Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity

    Falk Nimmerjahn;Robert M. Anthony;Jeffrey V. Ravetch

  • Antibodies, Fc receptors and cancer

    Falk Nimmerjahn;Jeffrey V Ravetch

Frequent Co-Authors

Jeffrey V. Ravetch
Jeffrey V. Ravetch Rockefeller University
Georg Schett
Georg Schett University of Erlangen-Nuremberg
Martin Herrmann
Martin Herrmann University of Erlangen-Nuremberg
Gerhard Krönke
Gerhard Krönke Charité - University Medicine Berlin
Jörg Köhl
Jörg Köhl University of Lübeck
Ralf Ludwig
Ralf Ludwig University of Rostock
Jeanette H. W. Leusen
Jeanette H. W. Leusen Utrecht University
Shozo Izui
Shozo Izui University of Geneva
Detlef Zillikens
Detlef Zillikens University of Lübeck
Anne Krug
Anne Krug Ludwig-Maximilians-Universität München

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare careers, often intertwined with nursing and advanced practice roles. For those looking to expand their clinical scope, transitioning from a Family Nurse Practitioner (FNP) to an Acute Care NP can be a valuable step. This pathway allows nurses to specialize in critical care settings, enhancing their expertise and opening new job opportunities. Learn more about this transition from fnp to acute care np.

Many students seeking accelerated routes into nursing can explore programs like the accelerated nurse practitioner program. These online degrees offer a compressed timeline without sacrificing quality, ideal for aspiring healthcare professionals who want to enter the workforce swiftly.

Non-nurses interested in joining the healthcare field might consider online ABSN programs tailored for career changers. These programs provide streamlined training and foundational knowledge in a flexible format. For more information on these accessible options, check out online absn programs for non nurses.

Additionally, for those focused on ease of entry, the easiest accelerated nursing programs to get into offer more accessible paths to achieving a BSN. These programs often have more flexible admission requirements, facilitating a smoother enrollment process while maintaining rigorous training standards.

Best Scientists Citing Falk Nimmerjahn

Trending Scientists

Recently Published Articles